Reyvow (Lasmiditan) for Migraine

Overview
Reyvow is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat acute migraine headaches with or without aura in adults. Reyvow is also known by its drug name, lasmiditan.

Reyvow is a serotonin (5-HT) 1F receptor agonist. They are believed to work by constricting blood vessels and reducing inflammation.

How do I take it?
Reyvow is taken as needed, up to 200 mg a day.

Reyvow comes in tablet form.

Side effects
The FDA-approved label for Reyvow lists common side effects including dizziness, fatigue, unusual sensations in the skin, and sleepiness.

Rare but serious side effects listed for Reyvow include serotonin syndrome, medication overuse headache, and central nervous syndrome depression.

For more details about this treatment, visit:

Reyvow – Eli Lilly
https://www.reyvow.com/